Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator
- 1 April 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (4) , 397-404
- https://doi.org/10.1016/s1081-1206(10)62485-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Glucocorticoids Inhibit Proliferation and Interleukin-4 and Interleukin-5 Secretion by Aeroallergen-Specific T-Helper Type 2 Cell LinesAnnals of Allergy, Asthma & Immunology, 1998
- Development of fluticasone propionate and comparison with other inhaled corticosteroidsPublished by Elsevier ,1998
- Efficacy and Safety of Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-γ production by cultured primary CD4+ T cellsJournal of Allergy and Clinical Immunology, 1997
- Dose-response Effect for Adrenal Suppression with Repeated Twice Daily Inhaled Fluticasone Propionate and Triamcinolone Acetonide in Adult AsthmaticsAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Glucocorticosteroids Inhibit Leukotriene ProductionAnnals of Allergy, Asthma & Immunology, 1997
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.American Journal of Respiratory and Critical Care Medicine, 1996
- Adverse effects of inhaled corticosteroidsThe American Journal of Medicine, 1995
- Cytokine Inhibition by A Novel Steroid, Mometasone FuroateImmunopharmacology and Immunotoxicology, 1991